• No results found

Peripheral blood stem cell

Original Article Unrelated-donor, peripheral blood stem cell transplantation in thalassemia major

Original Article Unrelated-donor, peripheral blood stem cell transplantation in thalassemia major

... Regular blood transfusion and iron-removal therapy are critical treatment methods for patients with β-thalassemia ...hematopoietic stem cell transplantation, patients may completely dispose of ...

8

Case Report Esophageal intramucosal hematoma after peripheral blood stem cell transplantation: case report and review of literature

Case Report Esophageal intramucosal hematoma after peripheral blood stem cell transplantation: case report and review of literature

... Abstract: Esophageal complications occur after hematopoietic stem cell transplantation (HSCT). There are, how- ever, only limited reports on the etiology or management of esophageal complications. Here, we ...

5

Evaluation of a biosimilar granulocyte colony-stimulating factor (filgrastim XM02) for peripheral blood stem cell mobilization and transplantation: a single center experience in Japan

Evaluation of a biosimilar granulocyte colony-stimulating factor (filgrastim XM02) for peripheral blood stem cell mobilization and transplantation: a single center experience in Japan

... line peripheral blood stem cell mobilization strategy in autologous hematopoieitic stem cell transplantation: a single center experience from ...for peripheral ...

8

Case Report Successful treatment with autologous peripheral blood stem cell transplantation for multiple myeloma concurrent systemic lupus erythematosus: a case report

Case Report Successful treatment with autologous peripheral blood stem cell transplantation for multiple myeloma concurrent systemic lupus erythematosus: a case report

... autologous peripheral blood stem cell transplantation in patients with MM and concurrent SLE has not been reported ...for peripheral blood stem cell transplantation ...

5

Ocular morbidity in bone marrow and peripheral blood stem cell transplant recipients

Ocular morbidity in bone marrow and peripheral blood stem cell transplant recipients

... Cyclosporine is a potent immunosuppressive agent. It can cause endothelial cell injury. Other side effects are nephrotoxicity, hypertension, seizures, encephalopathy, cortical blindness, cerebellar and spinal ...

81

Donating bone marrow or peripheral blood stem cells Information for the donor family

Donating bone marrow or peripheral blood stem cells Information for the donor family

... of stem cell collection will be ...procedure. Peripheral blood stem cell collection is the most common method of obtaining stem ...

8

Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation

Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation

... marrow, peripheral blood stem cell, or cord blood transplantation at Singapore General Hospital between January 2008 and September 2011 were included if they had an initial episode of ...

6

Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery

Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery

... hematopoietic stem/ progenitor cells (HSPCs) in a quiescent ...hematopoietic stem cell transplantation (HSCT) promotes hematopoiesis by inducing HSC ...hematopoietic cell recovery following ...

10

Herzog, Christine
  

(2004):


	Prädiktiver Wert des G-CSF-stimulierten Leukozytenwertes für die Blutstammzellsammlung nach IEV-Chemotherapie bei Lymphomen und multiplem Myelom.


Dissertation, LMU München: Medizinische Fakultät

Herzog, Christine (2004): Prädiktiver Wert des G-CSF-stimulierten Leukozytenwertes für die Blutstammzellsammlung nach IEV-Chemotherapie bei Lymphomen und multiplem Myelom. Dissertation, LMU München: Medizinische Fakultät

... of peripheral blood stem- cell and autologous bone marrow transplantation for lymphoma patients: A case- controlled analysis of the EBMT Registry ...

61

Recent Advances in Stem Cell Therapy for Myelodysplastic Syndromes

Recent Advances in Stem Cell Therapy for Myelodysplastic Syndromes

... allogeneic stem cell transplantation were proposed [53-56], as well as a reduction in allogeneic peripheral blood stem cell transplantation intensity [57, ...allogeneic ...

6

Case Report Late isolated extramedullary relapse of acute promyelocytic leukemia present as chronic otitis media: case report and literature review

Case Report Late isolated extramedullary relapse of acute promyelocytic leukemia present as chronic otitis media: case report and literature review

... Extramedullary relapse in the external auditory canal in a patient with acute promyelocytic leukemia treated with all-trans retinoic acid and autologous peripheral blood stem cell transp[r] ...

6

Nine Year Survival of Lymphoblastic Lymphoma Patients

Nine Year Survival of Lymphoblastic Lymphoma Patients

... apy regimens used were IMVP-16 (ifosphamide, mesna, methotrexate, etoposide), COPBLAM-V (cyclophosphamide, vincristine, prednisolone, bleomycin, adriamycin, procarbazine) and chemo- therapy regimens used in adolescent ...

9

Stem Cell Transplant (Peripheral Blood, Bone Marrow, and Cord Blood Transplants)

Stem Cell Transplant (Peripheral Blood, Bone Marrow, and Cord Blood Transplants)

... Cord blood transplant may be an option if a good match can’t be found among volunteer stem cell ...cord blood is generally best, studies suggest that cord blood doesn’t have to be as ...

35

Original Article Comparison of therapeutic efficacy and complications between autologous stem cell transplantation and chemotherapy for large B-cell lymphoma: a meta-analysis

Original Article Comparison of therapeutic efficacy and complications between autologous stem cell transplantation and chemotherapy for large B-cell lymphoma: a meta-analysis

... tologous peripheral blood stem cell transplan- tation for untreated high-intermediate-, and high-risk diffuse large B-cell lymphoma: a mul- ticenter prospective phase II study (JSCT- ...

9

Day 100 Absolute Monocyte/Lymphocyte Prognostic Score and Survival Post Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation in  Diffuse Large B Cell Lymphoma

Day 100 Absolute Monocyte/Lymphocyte Prognostic Score and Survival Post Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation in Diffuse Large B Cell Lymphoma

... post-autologous peripheral blood hematopoietic stem cell transplantation (APBHSCT) to predict clinical outcomes in diffuse large B-cell lymphoma (DLBCL) patients have not been ...

8

Iberian pig mesenchymal stem/stromal cells from dermal skin, abdominal and subcutaneous adipose tissues, and peripheral blood: in vitro characterization and migratory properties in inflammation

Iberian pig mesenchymal stem/stromal cells from dermal skin, abdominal and subcutaneous adipose tissues, and peripheral blood: in vitro characterization and migratory properties in inflammation

... The ability of MSCs to divide and differentiate could be assessed, at least in part, by evaluating their prolifera- tive capacity. One of the characteristics of mesenchymal cells is their almost unlimited proliferation ...

13

Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin’s lymphoma with an emphasis on targeted therapies and transplantation strategies

Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin’s lymphoma with an emphasis on targeted therapies and transplantation strategies

... 110. Weaver CH, Zhen B, Buckner CD. Treatment of patients with malignant lymphoma with mini-BEAM reduces the yield of CD34+ peripheral blood stem cells. Bone Marrow Transplant. 1998;21(11):1169–1170. ...

16

CD4+ T cells in aged or thymectomized recipients of allogeneic stem cell transplantations

CD4+ T cells in aged or thymectomized recipients of allogeneic stem cell transplantations

... analysis Peripheral blood mononuclear cells were isolated using Ficoll-Hypaque (Lymphoprep; Axis-shield, Oslo, Nor- way) and suspended in phosphate-buffered saline con- taining ...T cell Enrich- ment ...

8

Original Article Bioactivity of CD34+ cells in patients with acute-on-chronic liver failure

Original Article Bioactivity of CD34+ cells in patients with acute-on-chronic liver failure

... rate. Stem cells have been applied to replacement therapy, gene therapy and tissue engineering for its capacity of self-renewal and multi-lineage ...the peripheral blood hematopoietic stem ...

11

Hematopoietic stem cells from peripheral blood the perspective of non mobilized peripheral blood

Hematopoietic stem cells from peripheral blood the perspective of non mobilized peripheral blood

... cord blood progenitors ex- panded ex vivo in the presence of Notch ligand we in- fused in a clinical setting after a myeloablative prepara- tive regimen for stem cell transplantation, the time to ...

9

Show all 10000 documents...

Related subjects